CH655317A5 - Derives de l'acide 3-amino 2-oxo azetidine 1-sulfonique, leur preparation, medicaments et compositions les renfermant. - Google Patents

Derives de l'acide 3-amino 2-oxo azetidine 1-sulfonique, leur preparation, medicaments et compositions les renfermant. Download PDF

Info

Publication number
CH655317A5
CH655317A5 CH6166/82A CH616682A CH655317A5 CH 655317 A5 CH655317 A5 CH 655317A5 CH 6166/82 A CH6166/82 A CH 6166/82A CH 616682 A CH616682 A CH 616682A CH 655317 A5 CH655317 A5 CH 655317A5
Authority
CH
Switzerland
Prior art keywords
radical
formula
compound
amino
racemic
Prior art date
Application number
CH6166/82A
Other languages
English (en)
French (fr)
Inventor
Rene Heymes
Alain Bonnet
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Priority to CH326385A priority Critical patent/CH661504A5/fr
Publication of CH655317A5 publication Critical patent/CH655317A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CH6166/82A 1981-10-23 1982-10-22 Derives de l'acide 3-amino 2-oxo azetidine 1-sulfonique, leur preparation, medicaments et compositions les renfermant. CH655317A5 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CH326385A CH661504A5 (fr) 1981-10-23 1982-10-22 Derives de la 3-amino 2-oxo azetidine et leur preparation.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8119946A FR2515182B1 (fr) 1981-10-23 1981-10-23 Nouveaux produits derives de l'acide 3-amino 2-oxo azetidine 1-sulfamique, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation

Publications (1)

Publication Number Publication Date
CH655317A5 true CH655317A5 (fr) 1986-04-15

Family

ID=9263337

Family Applications (1)

Application Number Title Priority Date Filing Date
CH6166/82A CH655317A5 (fr) 1981-10-23 1982-10-22 Derives de l'acide 3-amino 2-oxo azetidine 1-sulfonique, leur preparation, medicaments et compositions les renfermant.

Country Status (12)

Country Link
JP (2) JPS58135883A (ko)
AT (1) AT382150B (ko)
BE (1) BE894785A (ko)
CA (1) CA1201439A (ko)
CH (1) CH655317A5 (ko)
DE (1) DE3239157C2 (ko)
FR (1) FR2515182B1 (ko)
GB (1) GB2111482B (ko)
IT (1) IT1157233B (ko)
LU (1) LU84434A1 (ko)
NL (1) NL8204089A (ko)
SE (2) SE461655B (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
MX7096E (es) * 1980-12-05 1987-06-19 Takeda Chemical Industries Ltd Metodo para preparacion de derivados de 2-oxoazetidina
US4675397A (en) * 1980-12-05 1987-06-23 Takeda Chemical Industries, Ltd. 1-sulfo-2-oxoazetidine derivatives and their production
US4673739A (en) * 1980-12-05 1987-06-16 Takeda Chemical Industries, Ltd. 4-carbamoyloxymethyl-1-sulfo-2-oxoazetidine derivatives and their production
US4572801A (en) * 1981-04-30 1986-02-25 Takeda Chemical Industries, Ltd. 4-Carbamoyloxymethyl-1-sulfo-2-oxoazetidine derivatives and their production
FR2558467B2 (fr) * 1981-10-23 1987-03-20 Roussel Uclaf Nouveau produit derive de l'acide 3-amino 2-oxo azetidine 1-sulfamique, son procede de preparation, son application comme medicament et un produit intermediaire necessaire a sa preparation
US4443374A (en) * 1982-02-01 1984-04-17 E. R. Squibb & Sons, Inc. Process for preparing (3S)-3-[[(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]-acetyl]amino]-2-oxo-1-azetidinesulfonic acid, and 4-substituted derivatives
JPS58208288A (ja) * 1982-05-31 1983-12-03 Banyu Pharmaceut Co Ltd ２−オキソ−１−アゼチジンスルホン酸誘導体
JPS59175490A (ja) * 1983-03-24 1984-10-04 Banyu Pharmaceut Co Ltd ２−オキソ−１−アゼチジンスルホン酸誘導体
EP0096296B1 (de) * 1982-06-03 1987-07-29 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft 1-Sulfo-2-oxoazetidinderivate
DE3377061D1 (en) * 1982-06-03 1988-07-21 Hoffmann La Roche Process for the preparation of 1-sulfo-2-oxoazetidine derivatives
JPS5982359A (ja) * 1982-11-02 1984-05-12 Kanegafuchi Chem Ind Co Ltd ４（Ｒ）配位光学活性β−ラクタム化合物の製法
EP0117053A1 (en) * 1983-02-10 1984-08-29 Ajinomoto Co., Inc. Azetidinone derivatives
JPS59231086A (ja) * 1983-06-15 1984-12-25 Teikoku Hormone Mfg Co Ltd ４−メトキシエチル−２−アゼチジノン−１−スルホン酸誘導体
US4501697A (en) * 1983-06-17 1985-02-26 E. R. Squibb & Sons, Inc. 4-[[(Amidomethyl)oxy]methyl]-2-oxo-1-azetidinesulfonic acid salts
JPS6097978A (ja) * 1983-10-31 1985-05-31 Otsuka Chem Co Ltd ３−アシルアミノ−４−メチル−２−アゼチジノン−１−スルホン酸誘導体，その製造方法および該誘導体を含有する薬剤
JPS60202882A (ja) * 1984-03-27 1985-10-14 Teikoku Hormone Mfg Co Ltd 新規な２−アゼチジノン−１−スルホン酸誘導体
WO1986006722A1 (en) * 1985-05-09 1986-11-20 The Upjohn Company Carbonate substituted monobactams as antibiotics
US4837318A (en) * 1985-05-09 1989-06-06 The Upjohn Company Carbonate substituted monobactams as antibiotics
DE19642530A1 (de) * 1996-10-15 1998-04-16 Bayer Ag Halogenalkoximinoessigsäureamide
US6677028B1 (en) 1999-09-10 2004-01-13 3M Innovative Properties Company Retroreflective articles having multilayer films and methods of manufacturing same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166816A (en) * 1975-05-05 1979-09-04 Smithkline Corporation Methods and intermediates for preparing cis-4-oxoazetidine intermediates
DK194776A (da) * 1975-05-05 1976-11-06 Smithkline Corp Antibakterielle midler og mellemprodukter dertil
FR2361885A1 (fr) * 1975-09-03 1978-03-17 Smithkline Corp Analogues de la penicilline, leurs intermediaires et procedes pour leur obtention
US4085100A (en) * 1976-11-01 1978-04-18 Smithkline Corporation Intermediate for dephthaloylation of azetidinone compounds
US4144333A (en) * 1976-11-15 1979-03-13 Smithkline Corporation Monocyclic beta-lactams with antibacterial activity
EP0005507A1 (de) * 1978-05-18 1979-11-28 Ciba-Geigy Ag Fragmentierungsverfahren von 3-(2-Hydroxyimino-acetylamino)-2-oxo-azetidin-Verbindungen und die erhaltenen Verbindungen
EP0021678B1 (en) * 1979-06-08 1984-11-07 Takeda Chemical Industries, Ltd. 1-sulpho-2-oxoazetidine derivatives, their production and pharmaceutical compositions thereof
NZ196202A (en) * 1980-02-07 1984-07-31 Squibb & Sons Inc Beta-lactam antibiotics (of azetidine-sulphonic acid type)
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
JPS57131758A (en) * 1980-12-05 1982-08-14 Takeda Chem Ind Ltd 1-sulfo-2-oxoazetidine derivative, its preparation and use
JPS58189176A (ja) 1982-04-30 1983-11-04 Takeda Chem Ind Ltd １−スルホ−２−アゼチジノン誘導体およびその製造法
JPS58210061A (ja) 1982-05-31 1983-12-07 Takeda Chem Ind Ltd １−スルホ−２−オキソアゼチジン誘導体、その製造法および用途
ATE24726T1 (de) * 1981-10-05 1987-01-15 Squibb & Sons Inc 4-aether-derivate von 2-azetidinon-1-sulfonsaeuren.
AU564150B2 (en) * 1982-04-30 1987-08-06 Takeda Chemical Industries Ltd. 1-sulfo-2-azetidinone derivatives
JPS59175490A (ja) * 1983-03-24 1984-10-04 Banyu Pharmaceut Co Ltd ２−オキソ−１−アゼチジンスルホン酸誘導体
HU189290B (en) * 1982-05-31 1986-06-30 Banyu Pharmaceutical Co Ltd,Jp Process for preparing new 2-oxo-1-azetidine-sulphonic acid derivatives and pharmaceutically acceptable salts thereof, further pharmaceutical compositions containing such derivatives as active substances
JPS58208288A (ja) * 1982-05-31 1983-12-03 Banyu Pharmaceut Co Ltd ２−オキソ−１−アゼチジンスルホン酸誘導体

Also Published As

Publication number Publication date
JPH04234844A (ja) 1992-08-24
FR2515182B1 (fr) 1986-05-09
IT1157233B (it) 1987-02-11
GB2111482B (en) 1985-11-06
AT382150B (de) 1987-01-12
SE8205870L (sv) 1983-04-24
GB2111482A (en) 1983-07-06
SE8702330L (sv) 1987-06-04
SE8702330D0 (sv) 1987-06-04
SE500849C2 (sv) 1994-09-19
BE894785A (fr) 1983-04-22
DE3239157C2 (de) 1994-04-28
DE3239157A1 (de) 1983-05-05
JPS58135883A (ja) 1983-08-12
CA1201439A (fr) 1986-03-04
NL8204089A (nl) 1983-05-16
FR2515182A1 (fr) 1983-04-29
SE8205870D0 (sv) 1982-10-15
IT8249341A0 (it) 1982-10-22
JPH0730018B2 (ja) 1995-04-05
SE461655B (sv) 1990-03-12
LU84434A1 (fr) 1983-06-13
JPH0471073B2 (ko) 1992-11-12
ATA391182A (de) 1986-06-15

Similar Documents

Publication Publication Date Title
CH655317A5 (fr) Derives de l'acide 3-amino 2-oxo azetidine 1-sulfonique, leur preparation, medicaments et compositions les renfermant.
CH633292A5 (fr) Oximes derivees de l'acide 3-acetoxymethyl 7-amino thiazolyl acetamido cephalosporanique, procede de preparation et compositions pharmaceutiques.
EP0034536A2 (fr) Nouvelles oximes dérivées de l'acide 3-alkyloxy ou 3-alkylthiométhyl 7-amino thiazolylacétamido céphalosporanique, leur préparation, leur application comme médicaments et les compositions les renfermant
CH622800A5 (ko)
CH622264A5 (en) Process for the preparation of new oximes, syn isomers, derived from 7-(aminothiazolylacetamido)cephalosporanic acid
EP0252823B1 (fr) Nouveaux dérivés du 1H, 3H-pyrrolo [1,2-c] thiazole, leur préparation et les compositions pharmaceutiques qui les contiennent
FR2667864A2 (fr) Derives de n-phenyl glycinamides, leur preparation et les medicaments les contenant.
EP0001193B1 (fr) Amino-acides cycliques, leurs procédés d'obtention et compositions pharmaceutiques les contenant
FR2472574A1 (fr) Derives de cephalosporine et composition pharmaceutique les contenant
EP0662971B1 (fr) DERIVES DE 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE, LEUR PREPARATION ET LES MEDICAMENTS LES CONTENANT
CH638221A5 (fr) Oximes derivees de l'acide 3-substitue 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et les compositions pharmaceutiques les renfermant.
CH629815A5 (en) Oximes derived from 7-(aminothiazolylacetamido)cephalosporanic acid, process of preparation and pharmaceutical compositions
EP0533827B1 (fr) Nouveaux derives de l'oxazole, leur preparation et les compositions pharmaceutiques qui les contiennent
CA1194873A (fr) Procede de preparation de nouveaux produits derives de l'acide 2-amino thiazolyl 2-oxyimino acetamido bicyclo-octene carboxylique
CH621555A5 (ko)
CH639388A5 (fr) Cephalosporines derivees de l'acide 7-/2-(2-amino 4-thiazolyl) 2-(carboxymethoxyimino) acetamido/ 3-substitue cephalosporanique, leurs procedes de preparation et medicaments les renfermant.
CH626088A5 (en) Process for the preparation of new oximes derived from 3-carbamoyloxymethyl-7-(aminothiazolylacetamido)cephalosporanic acid
EP0169755B1 (fr) Nouveaux dérivés de l'acide 4-hydroxy 3-quinoléine carboxylique subsititués en 2 par une fonction aminée, leur préparation, leur application comme médicaments, les compositions les renfermant et les intermédiaires nouveaux obtenus
CH651572A5 (fr) Alcoyloximes substituees derivees de l'acide 7-(2-amino 4-thiazolyl)acetamido cephalosporanique, leur preparation et les compositions les renfermant.
EP0072755A1 (fr) Nouveaux derivés de la cephalosporine, leur préparation et les médicaments qui les contiennent
CH638811A5 (fr) Oximes o-substituees derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique et les compositions pharmaceutiques les renfermant.
CH633016A5 (en) Oximes derived from 3-(thiadiazolylthiomethyl)-7-(aminothiazolylacetamido)cephalosporanic acid, process of preparation and pharmaceutical compositions
CH640858A5 (fr) Oximes derivees de l'acide 3-azidomethyl 7-amino thiazolyl acetamido cephalosporanique, leurs procedes de preparation et les medicaments les renfermant.
CH618177A5 (ko)
EP0659175B1 (fr) Derives d'(amino-3 phenyl)-1 ethanesulfonate d'alkylammonium optiquement actifs, leur preparation et leur utilisation

Legal Events

Date Code Title Description
PL Patent ceased